Results 121 to 130 of about 41,075 (183)

Acquired Pure Red Cell Aplasia Following BNT162b2 mRNA COVID-19 Vaccination. [PDF]

Intern Med
Hayase N, Kaneda Y, Fukuno K, Kanemura N.   +3 more
europepmc   +1 more source

Factors influencing Anti-SARS-CoV-2 IgG levels after vaccination in breast cancer patients. [PDF]

Discov Oncol
Shueng PW, Ting WC, Chang CC, Chang WW, Tseng YJ, Chang CF, Chen GD.   +6 more
europepmc   +1 more source

Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform. [PDF]

PLoS One
Volkman HR, de Munter L, Nguyen JL, Tran TMP, Mitratza M, Marques C, Choi L, Valluri S, Yang J, Antón A, Casas I, Conde-Sousa E, Drikite L, Grüner B, Icardi G, Ten Kate GL, Martin C, Mira-Iglesias A, Orrico-Sánchez A, Otero-Romero S, Rohde G, Jodar L, McLaughlin JM, Bollaerts K.   +23 more
europepmc   +1 more source

Correction: Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination. [PDF]

PLoS Pathog
PLOS Pathogens Editors.
europepmc   +1 more source

Signatures of Trained Immunity Following mRNA Vaccination: Differences Between mRNA-1273 and BNT162b2. [PDF]

J Clin Immunol
Kunc M, Whitehead BJ, Østergaard LJ, Tolstrup M, Benn CS, Wejse CM, Nejsum P.   +6 more
europepmc   +1 more source

Association between nucleic acid COVID-19 vaccines and acute myocardial infarction in adults: a systematic review. [PDF]

Front Cardiovasc Med
Castellanos-Hernández DI, Mayoral-Chávez MA, Matias-Cervantes CA, Alpuche J.   +3 more
europepmc   +1 more source

Humoral responses to wild type and ancient BA.1 SARS-CoV-2 variant after heterologous priming vaccination with ChAdOx1 nCoV-19 and BNT162b2 booster dose [PDF]

Atzori, Luigi, Campagna, Marcello, Caria, Paola, Chessa, Luchino, Coghe, Ferdinando, Costanzo, Giulia, Firinu, Davide, Galdiero, Massimiliano, Littera, Roberto, Manzin, Aldo, Marongiu, Alessandra, Palmas, Vanessa, Perra, Andrea, Piras, Cristina, Sanna, Giuseppina   +14 more
core   +1 more source

Effectiveness and Durability of the BNT162b2 KP.2 Vaccine Against COVID-19 Hospitalization and Emergency Department or Urgent Care Encounters in US Adults. [PDF]

Open Forum Infect Dis
Tartof SY, Frankland TB, Slezak JM, Ackerson BK, Puzniak L.   +4 more
europepmc   +1 more source

Temporal dynamics of SARS-CoV-2 antibodies and IgG subclasses following multiple doses and diverse COVID-19 vaccine combinations. [PDF]

Front Immunol
Meyer J, Hoerauf A, Dubiel AE, Kovačević P, Trudić A, Primorac D, Hübner MP, Adjobimey T, Parcina M.   +8 more
europepmc   +1 more source

Unraveling COVID-19-vaccination-induced bullous pemphigoid: a case report and review of the literature. [PDF]

J Med Case Rep
Chandrasekaran S, Kamboj M, Baddepudi S, Raj R, Suresh C, Sanker V, Dave T, Wijenaike N.   +7 more
europepmc   +1 more source